Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CACNA2D1 | P54289 | 2/20 | 0.34 |
| ▸ | CACNB3 | P54284 | 1/20 | 0.34 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.34 |
| ▸ | PGR | P06401 | 1/20 | 0.34 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.34 |
| ▸ | HTR2B | P41595 | 1/20 | 0.34 |
| ▸ | CACNA2D2 | Q9NY47 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | REN | P00797 | 1/20 | 0.33 |
| ▸ | ACE | P12821 | 1/20 | 0.33 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21273032 | 0.80 | — | — | |
| SCHEMBL6724603 | 0.80 | — | — | |
| SCHEMBL28424882 | 0.78 | SLC22A6 (0.38) | SLC22A6TSHRTDP1ALDH1A1CACNA2D1 | |
| SCHEMBL25751406 | 0.77 | TSHR (0.39) | TSHRTDP1ALDH1A1TGFBR1CA2 | |
| SCHEMBL1300654 | 0.77 | SLC22A6 (0.41) | SLC22A6TDP1ALDH1A1CYP1A2CACNA2D1 | |
| SCHEMBL27653781 | 0.76 | TDP1 (0.40) | SLC22A6TSHRTDP1SMN1; SMN2TGFBR1 | |
| SCHEMBL6140998 | 0.76 | SMN1; SMN2 (0.50) | SLC22A6TDP1SMN1; SMN2TGFBR1ALOX15 | |
| SCHEMBL13361506 | 0.75 | — | — | |
| SCHEMBL13460878 | 0.75 | — | — | |
| SCHEMBL18265596 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024048585-A1 | RUBBER-BONDED CELLULOSE FIBERS AND MANUFACTURING METHOD THEREFOR, RESIN COMPOSITION AND MANUFACTURING METHOD THEREFOR, AND CURABLE RESIN COMPOSITION | 株式会社クレハ | 2024-03-07 | — | — | WO | disclosed |
| EP-3696209-B1 | SHEET-MOLDING COMPOUND AND FIBER-REINFORCED COMPOSITE MATERIAL | MITSUBISHI CHEM CORP (JP) | 2023-08-02 | — | — | EP | disclosed |
| US-11286384-B2 | Resin composition, molded article, laminate, gas barrier material, coating material, and adhesive | DIC CORPORATION (JP) | 2022-03-29 | — | — | US | disclosed |
| EP-3208309-B1 | RESIN COMPOSITION AND PRESS-MOLDED ARTICLE OF SAME | MITSUBISHI CHEM CORP (JP) | 2020-11-25 | — | — | EP | disclosed |
| EP-3696209-A1 | SHEET-MOLDING COMPOUND AND FIBER-REINFORCED COMPOSITE MATERIAL | MITSUBISHI CHEMICAL CORPORATION (JP) | 2020-08-19 | — | — | EP | disclosed |
| EP-3263612-B1 | POLYMER POWDER, CURABLE RESIN COMPOSITION AND CURED MATERIAL THEREOF | MITSUBISHI CHEM CORP (JP) | 2020-08-05 | — | — | EP | disclosed |
| EP-3296359-B1 | SHEET-MOLDING COMPOUND AND FIBER-REINFORCED COMPOSITE MATERIAL | MITSUBISHI CHEM CORP (JP) | 2020-07-08 | — | — | EP | disclosed |
| US-20200055978-A1 | SHEET-MOLDING COMPOUND AND FIBER-REINFORCED COMPOSITE MATERIAL | MITSUBISHI CHEMICAL CORPORATION (JP) | 2020-02-20 | — | — | US | disclosed |
| US-10363724-B2 | Resin composition and compression-molded article of same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2019-07-30 | — | — | US | disclosed |
| EP-3162842-B1 | TOW PREPREG, COMPOSITE PRESSURE VESSEL, AND METHOD FOR MANUFACTURING SAME | MITSUBISHI CHEM CORP (JP) | 2019-04-17 | — | — | EP | disclosed |
| US-20160096955-A1 | Polymer Powder, Curable Resin Composition and Cured Material Thereof | MITSUBISHI RAYON CO., LTD. (JP) | 2016-04-07 | — | — | US | disclosed |
| US-9193812-B2 | Polymer powder, curable resin composition and cured material thereof | MITSUBISHI RAYON CO., LTD. (JP) | 2015-11-24 | — | — | US | disclosed |
| US-20140350186-A1 | Polymer Powder, Curable Resin Composition and Cured Material Thereof | MITSUBISHI RAYON CO., LTD. (JP) | 2014-11-27 | — | — | US | disclosed |
| EP-2796482-A1 | POLYMER POWDER, CURABLE RESIN COMPOSITION, AND CURED PRODUCT THEREOF | Mitsubishi Rayon Co., Ltd. (JP) | 2014-10-29 | — | — | EP | disclosed |
| EP-2664651-A1 | CROSSLINKED POLYMER PARTICLES FOR EPOXY RESINS, EPOXY RESIN COMPOSITION, AND CURED EPOXY ARTICLE | Mitsubishi Rayon Co., Ltd. (JP) | 2013-11-20 | — | — | EP | disclosed |
| US-20130289211-A1 | CROSS-LINKED POLYMER PARTICLE FOR EPOXY RESIN, EPOXY RESIN COMPOSITION, AND EPOXY CURED MATERIAL | MITSUBISHI RAYON CO., LTD. (JP) | 2013-10-31 | — | — | US | disclosed |
| EP-1719776-B1 | Process for producing a silicone compound | TORAY INDUSTRIES (JP) | 2013-10-09 | — | — | EP | disclosed |
| US-7683206-B2 | Silicone compound and process for producing the same | TORAY INDUSTRIES, INC. (JP) | 2010-03-23 | — | — | US | disclosed |
| US-20070191621-A1 | Silicone compound and process for producing the same | TORAY INDUSTRIES, INC. (JP) | 2007-08-16 | — | — | US | disclosed |
| EP-1719776-A1 | SILICONE COMPOUND AND PROCESS FOR PRODUCING THE SAME | TORAY INDUSTRIES, INC. (JP) | 2006-11-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070191621-A1 | Silicone compound and process for producing the same | F12, STS, SULT1A1 | SLC22A6 342/4885TSHR 2404/4885TDP1 4705/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.